US Patent Issued to China Medical University on March 3 for "Method and a kit for predicting the susceptibility to stimulator of interferon genes (STING) agonists in a cancer patient" (Taiwanese Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,681, issued on March 3, was assigned to China Medical University (Taichung City, Taiwan).

"Method and a kit for predicting the susceptibility to stimulator of interferon genes (STING) agonists in a cancer patient" was invented by Mien-Chie Hung (Taichung City, Taiwan) and Jung-Mao Hsu (Taichung City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for predicting susceptibility to stimulator of interferon genes (STING) agonists of a cancer patient is provided, comprising (1) obtaining at least one sample from the cancer patient; (2) detecting an expression level of S-methyl-5'-thioadenosine phosphorylase (MTAP) in the at least one samp...